U.S. CLINICAL NUTRITION MARKET ANALYSIS

U.S. clinical nutrition market is estimated to be valued at US$ 4.93 Bn in 2023 and is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).

Analysts’ Views on U.S. Clinical Nutrition Market:

Increasing geriatric population that are  prone to major life threatening diseases such as cancer, chronic diseases, and neurological disorders is expected to drive the U.S. clinical nutrition market growth. For instance, in October 2021, according to the World Health Organization (WHO) Prospectus, the number of individuals over the age of 60 were 1 billion in 2020, and this is expected to significantly increase to 1.4 billion by 2050. The world's population of adults of age 60 and older would have doubled (to 2.1 billion) by 2050.

Figure 1. U.S. Clinical Nutrition Market Share (%), By Type, 2023

To learn more about this report, request a free sample copy

U.S. Clinical Nutrition Market– Drivers

• Rising number of business development strategies by market players: Key players operating in the U.S. clinical nutrition market are adopting several business development strategies such as product launch to expand their product offerings, and this is expected to fuel the market growth over the forecast period. For instance, in June 2020, Otsuka Pharmaceutical Factory Inc., a pharmaceutical company, announced the launch of its new ENORAS Liquid for enteral use in coffee flavor and strawberry flavor. It is indicated for nutritional support in postoperative patients.
• Increasing prevalence of cancer: Increasing changes in lifestyles is considered a major cause of cancer. Thus, increasing prevalence of cancer globally is expected to boost growth of the U.S clinical nutrition market over the forecast period, as arrays are used in diagnostics for various indications such as cancer and others. For instance, in 2021, according to the data published by the American Cancer Society in 2021, cancer facts and figures in the U.S. reported the estimated number of cancer cases in the U.S. in 2021, which is provided below

ESTIMATED NEW CANCER CASES IN THE U.S. IN 2021

Figure 2. U.S. Clinical Nutrition Market Share (%), By Application, 2023

To learn more about this report, request a free sample copy

U.S. Clinical Nutrition Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization (WHO), declared it a public health emergency on January 30, 2020.

COVID-19 affected the economy in three main ways: by directly affecting the production and demand of drugs, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, the U.A.E., Egypt, and others faced problems regarding transportation of things from one place to another.

Increasing use of neutraceuticals and dietary supplements for older adults to recover from COVID-19 has boosted growth of the U.S. clinical nutrition market. For instance, in June 2022, according to a report published by Clinics in Geriatric Medicine, a diagnostic and therapeutic information center, on a report on neutraceuticals and dietary supplements for older adults with long COVID-19, age group of older adults had been affected most during COVID-19. Long COVID has a complex pathophysiology encompassing inflammatory and autoimmune processes, perturbations in metabolic pathways, and alterations in endothelial function and redox homeostasis. The management of COVID requires a multi-dimensional approach that should include a comprehensive nutritional assessment. Several foods with bio-active compounds, neutraceuticals, and supplements may target specific pathways involved in long COVID and may, therefore, be used as an adjunctive therapy to manage the condition.

U.S. Clinical Nutrition Market Segmentation:

U.S. clinical nutrition market is segmented into type, form, age group application, and end user.

• By type, the market is segmented into enteral nutrition (standard nutrition and disease specific nutrition) and parenteral nutrition {amino acids, carbohydrates, vitamins and minerals and others (fibers, etc.)}.Out of which, the enteral nutrition segment is expected to hold a dominant position in the U.S. clinical nutrition market during the forecast period, owing to easy availability of enteral nutritional product in the market by the market players.
• By form, the market is segmented into powder, liquid, and others (solid, etc.). Out of which, the powder segment is expected to hold a dominant position in the U.S. clinical nutrition market during the forecast period, owing to increasing product launch by the key market players.
• By age group, the market is segmented into infant nutrition, adult nutrition and geriatric nutrition. Out of which, the geriatric nutrition segment is expected to hold a dominant position in the U.S. clinical nutrition market during the forecast period, owing to increasing number of geriatric population.
• By application, the market is segmented into diabetes, gastrointestinal diseases, cancer, neurological disorder, metabolic syndrome, and other (Critical care, etc.). Out of which, the diabetes segment is expected to dominate the market over the forecast period owing to rising prevalence of diabetes in the U.S.
• By end user, the market is segmented into hospitals, home care setting, long term care facilities, ambulatory surgical centers, and others (Research Institutes, etc.). Out of which, the hospitals segment is expected to dominate the market over the forecast period owing to increasing number of hospitals in the U.S.
• Among all segments, the type segment has the highest potential due to the increasing growth strategies such as product launch by key market players. For instance, in September 2021, Abbott, a U.S.-based medical devices and healthcare company, announced the launch of its innovative childhood nutrition solution, the new PediaSure with arginine and natural vitamin K2 to support children's growth and development through proper nutrition.

U.S. Clinical Nutrition Market- Cross Sectional Analysis:

Rising number of new product launches related to powder form is expected to propel market growth in the U.S., over the forecast period. For instance, in January 2022, Danone S.A., a global food company, announced the launch of a powder version of medical nutrition drink named Souvenaid. Souvenaid is a food for special medical purposes in the dietary management of early Alzheimer's disease.

U.S. Clinical Nutrition Market: Key Developments

• On January 25, 2023, Nutricia, a subsidiary of Danone, a global multinational food-products manufacturing corporation, announced the launch of Fortimel, a plant-based oral nutritional supplement made from pea and soy protein that meets dietary needs of malnourished patients and those at risk of becoming malnourished
• In February 2022, Kate Farms, a U.S. based company that provides plant-based shakes and formulas, announced the launch of its newest shake, Glucose Support 1.2. This first-of-its-kind plant-based, organic nutrition shake is designed to manage blood sugar as part of a balanced diet. As the newest addition to the Kate Farms nutrition portfolio, Glucose Support 1.2 is created to deliver plant-based nutrition to patients living with diabetes.
• In August 2020, Otsuka Pharmaceutical Co., Ltd, a global pharmaceutical company, announced the launch of Enoras liquid, a nutritional product that is indicated to maintain the daily amount of vitamins and trace elements in the individuals and post-operative patients. Enoras liquid can be administered through a  feeding tube, and can be consumed through mouth by individuals.
• In June 2020, Arla Foods Ingredients, a global whey ingredient supplier, launched a new whey protein ingredient Lacprodan HYDRO.Rebuild that is clinically proven to counteract age-related muscle mass decline. It offers highly accessible content of branched-chain amino acids and essential amino acids such as leucine that are important for muscle synthesis in seniors, and also helps in improving the  muscle mass, strength, and mobility.

U.S. Clinical Nutrition Market: Key Trend

• Increasing preference for protein supplements for proper nutritional value: Increasing preference for protein supplements for proper nutritional value is expected to drive the U.S. clinical nutrition market growth over the forecast period. For instance, in December 2021, according to the report published by National Center for Biotechnology Information, on “Rational Use of Protein Supplements in the Elderly—Relevance of Gastrointestinal Mechanisms”, nutritional supplements including pure-protein or protein-enriched drinks are increasingly used by older people to maintain body weight and nutrition, and specifically to prevent or treat loss of muscle function, sarcopenia, and frailty. Protein supplements appear relatively safe, although care should be taken in those with or at risk of renal impairment, or prone to post-nutrient hypotension.

U.S. Clinical Nutrition Market: Restraint

• Side effects of nutritional products: The major factors restraining  growth of the U.S. clinical nutrition market is side effects and complications caused by products indicated for clinical nutrition, if consumed in excess. Excess consumption of any nutritional product can lead to life threating conditions. For example, parenteral nutritional therapy can lead to serious and life threating conditions such as refeeding syndrome or liver dysfunction. For instance, in December 2021, according to a study published by National Center for Biotechnology Information, refeeding syndrome describes the adverse medicinal and biochemical problems that may result from feeding malnourished patients through any route, be it oral, enteral or parenteral, whereas in 2020, 60% of the patients given parenteral nutrition were at risk of refeeding problems.

Counterbalance: To overcome these challenges, patient must consult their physician before taking any kind of clinical nutrition to avoid later consequences.

U.S. Clinical Nutrition Market - Key Players

Major players operating in the U.S. clinical nutrition market include Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Nestlé S.A., DANONE S.A., B. Braun Melsungen AG, Mead Johnson & Company LLC, Perrigo Company PLC., Leprino Foods Company, GSK plc., Sun Pharmaceutical Industries Ltd., Sanofi, BASF SE and DSM.

Definition: Nutrition is one of the basic components of life. It is an essential part of health care. Nutrition provides human beings with the required amount of proteins, carbohydrates, fats, water, vitamins, and minerals essential for proper cellular functioning and physiological activities, and to maintain energy balance in the body. U.S. clinical nutrition market is categorized on the basis of type as enteral nutrition and parenteral nutrition.